Meta-analysis of Clinical Outcomes According to Age in T2DM Patients Initiating Insulin Glargine

被引：0
|
作者：
Haak, Thomas J.
Traylor, Louise
Landgraf, Wolfgang
Owens, David R.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1006-P
引用
收藏
页码：A256 / A257
页数：2
相关论文
共 50 条
  • [1] Local Tolerability of Insulin Degludec is Comparable to Insulin Glargine: A Meta-Analysis of T1DM and T2DM
    Meneghini, Luigi F.
    Schumm-Draeger, Petra-Maria
    Harris, Stewart
    Gall, Mari-Anne
    Lassota, Nathan
    Christiansen, Jens S.
    [J]. DIABETES, 2012, 61 : A230 - A230
  • [2] Influence of Gender on Glycemic Control and Hypoglycemia in T2DM Patients Initiating Insulin Glargine
    Kautzky-Willer, Alexandra
    Traylor, Louise
    Landgraf, Wolfgang
    Charbonnel, Bernard
    [J]. DIABETES, 2015, 64 : A257 - A257
  • [3] Effect of Body Mass Index (BMI) on Outcomes in T2DM Patients Initiating Insulin Glargine by Concomitant Oral Therapy
    Porcellati, Francesca
    Traylor, Louise
    Landgraf, Wolfgang
    Bolli, Geremia B.
    [J]. DIABETES, 2015, 64 : A560 - A560
  • [4] NEW INSULIN GLARGINE 300 U/ML: GLYCEMIC CONTROL AND HYPOGLYCEMIA IN A META-ANALYSIS OF EDITION CLINICAL TRIALS IN PEOPLE WITH T2DM
    Ritzel, R. A.
    Roussel, R.
    Bolli, G. B.
    Vinet, L.
    Yki-Jarvinen, H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A16 - A17
  • [5] Safety and efficacy comparison of different insulin regimens in T2DM patients: A meta-analysis
    Gao, Xueying
    Cai, Xiaoling
    Yang, Wenjia
    Ji, Linong
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S197 - S197
  • [6] Evaluation of Immunogenicity of LY2963016 Insulin Glargine Compared with Lantus® Insulin Glargine in Patients with T1DM or T2DM
    Deeg, Mark
    Ilag, Liza
    Huster, William J.
    Pollom, Robyn K.
    Zielonka, Jason
    Prince, Melvin J.
    Konrad, Robert J.
    [J]. DIABETES, 2014, 63 : A19 - A19
  • [7] NEW META-ANALYSIS OF PATIENT-LEVEL DATA ON EFFICACY AND HYPOGLYCAEMIA WITH INSULIN GLARGINE OR NPH INSULIN IN TYPE 2 DIABETES MELLITUS (T2DM) ACCORDING TO CONCOMITANT ORAL THERAPY
    Owens, D. R.
    Trayor, L.
    Landgraf, W.
    Mullins, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A335 - A335
  • [8] Efficacy and Safety in Persons with T2DM Treated with Insulin Glargine Plus Thrice-Daily Insulin Glulisine: A Meta-analysis of Four Studies
    Owens, David R.
    Traylor, Louise
    Landgraf, Wolfgang
    Porcellati, Francesca
    Bolli, Geremia B.
    [J]. DIABETES, 2015, 64 : A269 - A269
  • [9] All-Cause Mortality Comparison of Different Insulin Regimens in T2DM Patients: A Meta-analysis
    Gao, Xueying
    Cai, Xiaoling
    Yang, Wenjia
    Ji, Linong
    [J]. DIABETES, 2016, 65 : A251 - A251
  • [10] Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis
    Liu, Chen-Qian
    Sun, Jian-Xuan
    Xu, Jin-Zhou
    Qian, Xiao-Yuan
    Hong, Sen-Yuan
    Xu, Meng-Yao
    An, Ye
    Xia, Qi-Dong
    Hu, Jia
    Wang, Shao-Gang
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
12345